Frequency and Predictors of loss of Response to Infliximab or Adalimumab in Crohn’s Disease after One-Year Treatment Period – A Single Center Experience

Molnár, T ✉ [Molnár, Tamás (belgyógyászat-gas...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Farkas, K [Farkas, Klaudia (Belgyógyászat-gas...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Nyári, T [Nyári, Tibor András (Onkológia/epidemi...), author] Department of Medical Physics and Informatics (SZTE / ASZMS); Szepes, Z [Szepes, Zoltán (belgyógyászat, ga...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Nagy, F [Nagy, Ferenc (Gastroenterológia), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Wittmann, T [Wittmann, Tibor (Emésztőszervek be...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine)